Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.0559 | 0.064 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.0559 | 0.056 |
Echinococcus granulosus | peregrin | 0.0035 | 0.0806 | 0.2114 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.0559 | 0.064 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.2203 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0019 | 0.0022 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0837 | 0.0221 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0837 | 0.0959 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.2203 | 0.7105 |
Schistosoma mansoni | bromodomain-containing nuclear protein 1 brd1 | 0.0035 | 0.0806 | 0.1069 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0074 | 0.0085 |
Onchocerca volvulus | Alhambra homolog | 0.0035 | 0.0806 | 0.0262 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.218 | 0.2498 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 0.3742 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.48 | 0.5461 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.2203 | 0.5867 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.0559 | 0.056 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.1312 | 0.3472 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0837 | 0.0881 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0837 | 1 |
Echinococcus multilocularis | lamin | 0.0028 | 0.0559 | 0.1449 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0837 | 0.1203 |
Plasmodium falciparum | phd finger protein, putative | 0.0035 | 0.0806 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.2203 | 0.7105 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0837 | 0.1203 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.054 | 0.0618 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.1078 | 0.2242 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.48 | 0.55 |
Onchocerca volvulus | 0.0036 | 0.0837 | 0.0295 | |
Brugia malayi | PHD-finger family protein | 0.0035 | 0.0806 | 0.0846 |
Echinococcus granulosus | lamin | 0.0028 | 0.0559 | 0.1449 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0035 | 0.0806 | 0.0924 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0806 | 0.1069 |
Giardia lamblia | PHD finger protein 15 | 0.0035 | 0.0806 | 0.5 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.2203 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0043 | 0.1078 | 0.1235 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0559 | 0.064 |
Echinococcus multilocularis | PHD finger protein rhinoceros | 0.0035 | 0.0806 | 0.2114 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0837 | 0.1203 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.2203 | 0.5 |
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.2873 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.2203 | 1 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0788 | 0.2067 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0837 | 0.1203 |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.0559 | 0.1449 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.8727 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0115 | 0.3742 | 0.4239 |
Brugia malayi | Bromodomain containing protein | 0.0035 | 0.0806 | 0.0846 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.48 | 0.55 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0036 | 0.0837 | 0.2197 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 0.3742 | 1 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.1312 | 0.3472 |
Echinococcus granulosus | PHD finger protein rhinoceros | 0.0035 | 0.0806 | 0.2114 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.1078 | 0.2242 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.8727 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.0559 | 0.1449 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0837 | 0.2197 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.0559 | 0.1449 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1728 | 0.198 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.1078 | 0.2843 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0806 | 0.0924 |
Echinococcus multilocularis | musashi | 0.0028 | 0.0559 | 0.1449 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.2203 | 0.5867 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0043 | 0.1078 | 0.2843 |
Brugia malayi | jmjC domain containing protein | 0.0043 | 0.1078 | 0.1159 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0837 | 0.2197 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.2203 | 0.5 |
Echinococcus multilocularis | peregrin | 0.0035 | 0.0806 | 0.2114 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.2203 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.5623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.